Loading cancer entity…
Loading cancer entity…
Clinical trials
6,746 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,045)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00356122 | Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 53 | SanofiINDUSTRY | 1 | Oct 17, 2011 | clinicaltrials |
| NCT00451880 | Study of XL281 in Adults With Solid Tumors | completed | Phase 1 | 180 | ExelixisINDUSTRY | 1 | Oct 13, 2011 | clinicaltrials |
| NCT01103089 |
| Observations From Long Term Responders in the Gefitinib (Iressa) Expanded Access Program (EAP) |
| completed |
| — |
| 10 |
| AstraZenecaINDUSTRY |
| 1 |
| Oct 12, 2011 |
| clinicaltrials |
| NCT01442909 | Pemetrexed Followed by Docetaxel or in Reverse Sequence | completed | Phase 4 | 44 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Sep 29, 2011 | clinicaltrials |
| NCT00516022 | Mistletoe as Complementary Treatment in Patients With Advanced Non-small-cell Lung Cancer (NSCLC), Treated With Carboplatin/Gemcitabine Chemotherapy Combination.(Iscador) | completed | Phase 2 | 79 | Rambam Health Care CampusOTHER | 1 | Sep 27, 2011 | clinicaltrials |
| NCT00749346 | NovoTTF-100L in Combination With Pemetrexed (Alimta®) for Advanced Non-small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 42 | NovoCure Ltd.INDUSTRY | 1 | Sep 27, 2011 | clinicaltrials |
| NCT01112631 | Prospective Study of Quality of Life in Non-small Cell Lung Cancer (NSCLC) Patients Treated With/Without Postoperative Radiotherapy | completed | — | 293 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Sep 20, 2011 | clinicaltrials |
| NCT00686322 | Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC) | completed | Phase 4 | 6 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Sep 15, 2011 | clinicaltrials |
| NCT00752115 | Combination Chemotherapy With Sildenafil Plus Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 / Phase 3 | 120 | Hamamatsu UniversityOTHER | 1 | Sep 7, 2011 | clinicaltrials |
| NCT00881296 | Gemcitabine and Carboplatin for Elderly Patient With Lung Cancer(GEEP) | completed | Phase 2 | 60 | Hamamatsu UniversityOTHER | 1 | Sep 7, 2011 | clinicaltrials |
| NCT00520676 | Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer | completed | Phase 3 | 260 | Eli Lilly and CompanyINDUSTRY | 6 | Aug 10, 2011 | clinicaltrials |
| NCT00862030 | CT-Based Versus Conventional Simulation for Palliative Radiotherapy of Non-Small Cell Lung Cancer | completed | — | 20 | Alberta Health servicesOTHER | 1 | Aug 8, 2011 | clinicaltrials |
| NCT01185314 | To Study the Changes in Protein in Lung Cells of Asian Patients With Advanced Non-small Cell Lung Cancer (NSCLC)(PIONEER) | completed | N/A | 1,270 | AstraZenecaINDUSTRY | 7 | Aug 8, 2011 | clinicaltrials |
| NCT00115518 | Radiation Plus Cetuximab in Locally Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 30 | Heidelberg UniversityOTHER | 1 | Aug 5, 2011 | clinicaltrials |
| NCT00040638 | Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 40 | TelikINDUSTRY | 1 | Jul 25, 2011 | clinicaltrials |
| NCT00047801 | Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel in Platinum-Resistant Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 28 | TelikINDUSTRY | 1 | Jul 25, 2011 | clinicaltrials |
| NCT00077883 | TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 50 | TelikINDUSTRY | 1 | Jul 25, 2011 | clinicaltrials |
| NCT00708812 | Paclitaxel Plus Carboplatin With or Without Endostar in Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 126 | Shandong Simcere-Medgenn Bio-pharmaceutical Co., LtdINDUSTRY | 1 | Jul 21, 2011 | clinicaltrials |
| NCT00522886 | Phase I Cetuximab and Concurrent Radio-chemotherapy | completed | Phase 1 | 24 | Maastricht Radiation OncologyOTHER | 1 | Jul 19, 2011 | clinicaltrials |
| NCT01282450 | Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone for Patients With Oligo-metastatic Stage IV Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 60 | Maastricht Radiation OncologyOTHER | 1 | Jul 19, 2011 | clinicaltrials |
| NCT00509457 | GV 1001 Immunotherapy in Patients With Non-small Cell Lung Cancer (NSCLC) | completed | N/A | 20 | Oslo University HospitalOTHER | 1 | Jul 1, 2011 | clinicaltrials |
| NCT00293085 | An Open, Randomized, Multicentre, Phase II Pilot Study | completed | Phase 2 | 37 | Central European Cooperative Oncology GroupOTHER | 0 | Jun 23, 2011 | clinicaltrials |
| NCT00531401 | Study of Salirasib to Treat Non-Small Cell Lung Cancer | completed | Phase 2 | 71 | Concordia Pharmaceuticals, IncINDUSTRY | 1 | Jun 9, 2011 | clinicaltrials |
| NCT00343291 | A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC | completed | Phase 2 | 121 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 7, 2011 | clinicaltrials |
| NCT00614965 | Irinotecan Plus Cisplatin vs Pemetrexed Plus Cisplatin as 2nd Line in NSCLC Stage IIIB/IV | completed | Phase 2 | 124 | Hellenic Oncology Research GroupOTHER | 1 | May 23, 2011 | clinicaltrials |
| NCT00076388 | Iressa Versus Docetaxel (Taxotere) | completed | Phase 3 | 1,440 | AstraZenecaINDUSTRY | 25 | May 13, 2011 | clinicaltrials |
| NCT01024062 | Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 60 | Bristol-Myers SquibbINDUSTRY | 0 | Apr 25, 2011 | clinicaltrials |
| NCT00602433 | Hormone Changes in Women With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Receiving Erlotinib | completed | — | 10 | Northwestern UniversityOTHER | 1 | Apr 15, 2011 | clinicaltrials |
| NCT00391274 | Chemotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 211 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 12, 2011 | clinicaltrials |
| NCT00737867 | Vinorelbine/Gemcitabine Versus Vinorelbine/Carboplatin in Advanced Non-small Cell Lung Cancer | completed | Phase 3 | 444 | The Norwegian Lung Cancer Study GroupNETWORK | 1 | Apr 4, 2011 | clinicaltrials |
| NCT00540241 | Performance Status During Treatment With Pemetrexed in Patients With NSCLC(PERFORMANCE) | completed | — | 542 | Eli Lilly and CompanyINDUSTRY | 1 | Mar 29, 2011 | clinicaltrials |
| NCT00687817 | Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer | completed | Phase 2 | 49 | Peregrine PharmaceuticalsINDUSTRY | 1 | Mar 24, 2011 | clinicaltrials |
| NCT01081496 | Epidemiological Study to Evaluate the Prevalence of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC)(Spanish REASON) | completed | — | 1,000 | AstraZenecaINDUSTRY | 1 | Mar 16, 2011 | clinicaltrials |
| NCT00372775 | Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases | completed | Phase 2 | 66 | PfizerINDUSTRY | 4 | Feb 24, 2011 | clinicaltrials |
| NCT00252759 | Iressa Case Control Study in Japan | completed | — | 6,000 | AstraZenecaINDUSTRY | 1 | Jan 28, 2011 | clinicaltrials |
| NCT00255489 | A Phase I Study of ZD1839 and Palliative Thoracic Radiotherapy in Patients With Non-small-cell Lung Cancer | completed | Phase 1 | 36 | AstraZenecaINDUSTRY | 1 | Jan 25, 2011 | clinicaltrials |
| NCT00819728 | Trial of Weekly Taxotere and Irinotecan (CPT-11) in Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 35 | SanofiINDUSTRY | 1 | Jan 11, 2011 | clinicaltrials |
| NCT00609518 | A Study for Patients With Non-Squamous Non-Small Cell Lung Cancer | completed | Phase 2 | 111 | Eli Lilly and CompanyINDUSTRY | 4 | Dec 28, 2010 | clinicaltrials |
| NCT00321815 | Trial Of Erlotinib With Or Without PF-3512676 In Advanced Non Small Cell Lung Cancer | completed | Phase 2 | 43 | PfizerINDUSTRY | 1 | Dec 23, 2010 | clinicaltrials |
| NCT00061451 | Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Clinical Trial | completed | Phase 2 | 48 | Eli Lilly and CompanyINDUSTRY | 1 | Dec 22, 2010 | clinicaltrials |
| NCT00432640 | Assessment of Surgical sTaging vs Endoscopic Ultrasound in Lung Cancer: a Randomized Clinical Trial (ASTER Study) | completed | N/A | 240 | University Hospital, GhentOTHER | 3 | Dec 16, 2010 | clinicaltrials |
| NCT01261585 | Study of the Fixation of Various Vectors in PET/CT in Patients With a With Lung Cancer Before and During of CRT or RT(RTEP4) | completed | — | 5 | Centre Henri BecquerelOTHER | 1 | Dec 16, 2010 | clinicaltrials |
| NCT00192036 | Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer | completed | Phase 2 | 49 | Eli Lilly and CompanyINDUSTRY | 1 | Dec 9, 2010 | clinicaltrials |
| NCT00434668 | Evaluation of Tolerability of Adjuvant Cisplatin/Docetaxel in Completely Resected Stage IB/II Non-Small Cell Lung Cancer(TOLEDO) | completed | Phase 2 | 99 | University Hospital, AntwerpOTHER | 1 | Nov 30, 2010 | clinicaltrials |
| NCT00380718 | Chemotherapy for Patients With Non-Small Cell Lung Cancer | completed | Phase 4 | 33 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 16, 2010 | clinicaltrials |
| NCT00222404 | Pharmacogenomic Study Realized on "Non-small Cell Lung Carcinoma"(Pharmacogenos) | completed | — | 556 | University Hospital, GrenobleOTHER | 1 | Nov 5, 2010 | clinicaltrials |
| NCT00101920 | ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) | completed | Phase 2 | 50 | AmgenINDUSTRY | 0 | Oct 15, 2010 | clinicaltrials |
| NCT00350792 | Pemetrexed/Carboplatin Non-Small Cell Lung Cancer (NSCLC) Elderly Patients | completed | Phase 2 | 62 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 13, 2010 | clinicaltrials |
| NCT00085813 | Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer | completed | Phase 2 | 70 | GlaxoSmithKlineINDUSTRY | 3 | Oct 4, 2010 | clinicaltrials |
Data updated 23 days agoSource updated Oct 17, 2011source: clinicaltrials